Lexaria Bioscience Stock Price

0.18 (5.86%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 30,451
Bid Price 2.26
Ask Price 3.30
News -
Day High 3.29


52 Week Range


Day Low 2.96
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Lexaria Bioscience Corporation LEXX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.18 5.86% 3.25 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.99 2.96 3.29 3.29 3.07
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
221 30,451 $ 3.21 $ 97,716 - 1.85 - 12.50
Last Trade Time Type Quantity Stock Price Currency
17:40:13 10 $ 3.25 USD


Draw Mode:

Lexaria Bioscience Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 19.34M 5.95M 4.04M $ 722.74k $ - -0.89 -2.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 20.20k 70.30%

more financials information »

Lexaria Bioscience News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LEXX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.,4211.0749.08%
1 Month2.053.291.952.3659,2051.2058.54%
3 Months3.314.831.853.761,002,673-0.06-1.81%
6 Months4.194.941.853.76501,151-0.94-22.43%
1 Year6.6812.501.856.00615,927-3.43-51.35%
3 Years4.0512.501.856.06625,501-0.80-19.75%
5 Years4.0512.501.856.06625,501-0.80-19.75%

Lexaria Bioscience Description

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio.
Your Recent History
Lexaria Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220625 20:41:20